RxDoctor Payments Data

Yosef Kahn, MD

Clinical Cardiac Electrophysiology · South Bend, INNPI 1255538898

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $5,126 of the $6,503 with a category attached, or 78.8%. Abbott accounts for 64.5% of it on its own, with 15 other manufacturers making up the rest. 2025 is the largest year on record at $2,882, 3.2 times the $908 reported in 2019. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in IN, where the typical reported total is $13,586.

$6,503in general payments, 2019–2025

Across 155 payments — averaging $41.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$4K
  • Medtronic$1K
  • Medicomp Inc$178
  • Baxter Healthcare$176
  • Inari Medical, Inc.$145
  • Bardy Diagnostics, Inc.$125
  • plus $310 from 10 others

What the payments were for

  • Travel & lodging$1,37721%
  • Food & beverage$5,12679%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,503 in reported general payments places this provider in the 30th percentile of 72 clinical cardiac electrophysiology providers in Indiana.

See all clinical cardiac electrophysiology providers in Indiana

Medicare billing

Part B allowed, 2024
$145,532
Medicare patients
671
Services billed
2,219

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban433$398,357
XareltoRivaroxaban96$106,385
CorlanorIvabradine Hcl21$15,514
EntrestoSacubitril/Valsartan23$15,362
Flecainide Acetate161$7,059
Propafenone Hcl ErPropafenone Hcl13$4,442
Amiodarone Hcl288$4,082
Mexiletine Hcl21$4,010
Metoprolol Succinate272$3,345
SotalolSotalol Hcl51$1,614
Carvedilol201$1,205
Metoprolol Tartrate119$1,012
Digoxin28$608
Losartan Potassium37$557
Amlodipine Besylate90$466

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$39$106,38596 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 30th percentile of 72 clinical cardiac electrophysiology providers in Indiana.

Other clinical cardiac electrophysiology in South Bend

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →